October 29th 2024, 5:00pm
By Alex Biese
An expert answers prostate cancer questions from a recent CURE Educated Patient Summit.
October 29th 2024, 3:00pm
By Darlene Dobkowski, MA
Jylamvo is an oral liquid formulation of methotrexate originally approved in 2022 for adults with acute lymphoblastic leukemia, among other diseases.
October 29th 2024, 1:00pm
An expert told CURE that patients with cancer should discuss palliative care options with their team “as early as possible.”
October 28th 2024, 9:00pm
This trial will assess an individualized neoantigen therapy plus Keytruda in some patients with non-small cell lung cancer.
October 28th 2024, 7:00pm
By Spencer Feldman
Stivarga improved survival and delayed disease progression in patients with refractory advanced gastric and esophagogastric junction cancer.
October 28th 2024, 5:00pm
By Carla Deschamps
Carla Deschamps shares her experience with colon cancer and how her brother, sisters and parents helped her through the journey.
October 28th 2024, 4:29pm
By Joseph F. Renzulli MD, FACS
Panelists discuss how a comprehensive treatment approach for advanced prostate cancer involves considering various patient-specific factors, the transformative role of androgen receptor pathway inhibitors (ARPIs), and the necessity of early and aggressive intervention, while emphasizing the importance of clear communication between oncologists and patients regarding treatment expectations and options.
Panelists discuss how assessing patients' responses to treatment and addressing common adverse effects are essential for effective management of advanced prostate cancer, while also highlighting the importance of patient education and preparation before starting therapy.
October 28th 2024, 3:00pm
By Ashley Chan
Receiving radiation therapy for breast cancers harboring TP53 germline variants may cause secondary cancers, but risk estimates are unconfirmed.
October 28th 2024, 1:00pm
An expert discussed how liquid and tissue biopsies can help monitor treatment and detect potential resistance in patients with non-small cell lung cancer.
October 27th 2024, 5:00pm
By Dr. Nancy Lin
Two colleagues of an oncology nurse highlight her utmost respect for patients and as a liaison to the greater team.
October 26th 2024, 6:00pm
By Barbara Van Nostrand
When I was diagnosed with a rare and aggressive kidney cancer, I turned to God and He has helped me through my journey, each step of the way.
October 26th 2024, 2:00pm
Through regular follow-ups and symptom assessments, breast cancer survivors have the access to physical and emotional support they may need.
October 25th 2024, 9:00pm
The FDA has accepted a new drug application for the glioma-imaging agent Pixclara, with a decision expected next year.
October 25th 2024, 7:00pm
Researchers have found that engaging in aerobic physical activity results in modest depression reduction among some patients with cancer.
Standing Up to Cancer and How I Do it
Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera
Biopsy Alone May Miss Risk in Grade Group 1 Prostate Cancer
HMAs Underutilized in Older, Female and Non-White Patients with MDS